In this resource library we share documents, presentations, forms, videos and useful links from Pinnacle and the wider sector.
Use the search box and filters to help find what you're looking for or view all COVID-19 resources
Can't find what you need? Try searching in programmes.
Pneumonia is a significant cause of mortality in children and older people, particularly among Māori and Pacific peoples. Prompt identification and treatment will enable patients with initially less severe community-acquired pneumonia to be managed at home, reducing hospitalisation and mortality.
Point of care testing (POCT) capability is becoming increasingly available in general practice. POCT enables rapid clinical decision-making, an increased likelihood of keeping people well and closer to home (by avoiding referral to hospital) and addresses rural inequities which may be compounded by distance and infrastructure. Pinnacle has developed guidance for quality control of POCT in general practice and a POCT adverse events monitoring system.
Dr Tony Muller, psychiatrist, is able to review special authority (SA) requests for methylphenidate and dexamfetamine, and apply for them if the information supplied confirms the appropriateness of continued treatment. In the majority of cases Dr Muller can action these without needing a psychiatric assessment.
National Cervical Screening Programme (NCSP) screening updates.
Resources related to pre-call and recall for 6-week immunisations.
These terms and conditions relate to contracts between providers of services and any of the group's entities.
Advice and resources to assist you in offering virtual care.
This BPAC resource assists to predict risk of serious illness in children with fever
From support with new role implementation such as primary care assistants (PCAs) to mapping and redesign of current processes such as repeat prescribing processes, your local Pinnacle development manager can support your changing practice needs.
The national screening programme for cervical screening has been one of the most successful programmes in the world to reduce the incidence and death from cervical cancer. Since the programme has begun we've seen a steady decline in cervical cancer deaths - by about 60 per cent.